Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market Insights
Human papillomavirus (HPV) and Cytomegalovirus (CMV) are viral pathogens. HPV is a different virus than HIV (Human Immunodeficiency Virus) and HSV (Herpes Simplex Virus). HPV causes sexually transmitted infection. HPV is a major cause of cervical, vulva, vagina, penis, anus, mouth, and throat cancer. CMV is the most common herpesvirus infection. These infections can spread through sexual and non-sexual contact with body secretions (fluids).
The global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market was valued at US$ 3,006.4 million in 2018, and is expected to witness a CAGR of 6.0% during the forecast period (2018– 2026).
Figure 1. Global Human Papillomavirus (HPV) and (CMV) Cytomegalovirus Therapeutics Market Value Analysis (US$ Mn) and Y-o-Y Growth (%)
Source: Coherent Market Insights Analysis (2019)
Increasing number of sexually transmitted infections is expected to drive growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market
Increasing number of sexually transmitted infections is one of major drivers for the market growth. For instance, according to World Health Organization’s (WHO) report in 2019, over 290 million women suffer from HPV infection worldwide, annually and over 1 million people suffer from sexually transmitted infections (STIs) every day, worldwide.
Moreover, increasing approvals for vaccines is expected to boost the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market growth. For instance, in October 2018, the U.S Food and Drug Administration (FDA) approved Gardasil 9 ( HPV 9-valent vaccine), developed by Merck & Co., Inc. Gardasil 9 is used for cervical, vulvar, vaginal, and anal cancers caused by HPV types.
Global Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market- Regional Analysis
Regional segmentation of the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market is expected to account for the largest market share, owing to increasing initiatives for treatment of cervical cancer by health regulatory authorities in this region. For instance, in November 2018, the Pan American Health Organization (PAHO) launched its Communication Campaign with the slogan, ‘Don’t let cervical cancer stop you’. The aim of the campaign was to create awareness among the people for prevention of cervical cancer (caused by HPV infection).
Furthermore, Asia Pacific is projected to witness significant growth in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market during the forecast period, owing to increasing partnership of hospitals for the treatment of cervical cancer. For instance, in May 2019, Parirenyatwa Hospital (Zimbabwe’s largest referral hospitalannounced its partnership with China's Hunan Provincial Maternal Hospital. Under this partnership, both hospitals offer free cervical cancer screening and treatment to women in Zimbabwe.
Europe is also expected to gain significant share in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market over the forecast period, attributed to increasing products upgrade by key players. For instance, in March 2015, Fujirebio Europe upgraded its HPV genotyping panel with the launch of its new INNO-LiPA HPV Genotyping Extra II assay. It is used for HPV type specific patient monitoring and cervical cancer treatment.
Figure 2: Global Human Papillomavirus (HPV) and (CMV) Cytomegalovirus Therapeutics Market Value (US$ Mn), By Region, 2018
Source: Coherent Market Insights Analysis (2019)
Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market - Competitive Landscape
Key players operating in the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market include, Allergan, Bausch Health, GlaxoSmithKline, Lee’s Pharmaceutical Holdings, Merck Sharp & Dohme, Fougera Pharmaceuticals, Clinigen Group plc, Perrigo Company plc, Roche Holding AG, Biotest AG, and Fresenius Kabi.
Cytomegalovirus (CMV) infections spread through body fluids such as saliva, semen, breast milk, and urine. Signs and symptoms of the infections include, fatigue, fever, diarrhea, pneumonia, and hepatitis, shortness of breath, gastrointestinal ulceration, and bleeding.
Although no treatment for the infection caused by human papillomavirus (HPV) is available, symptoms can be treated. Most sexually active men and women suffer from HPV infections. The infections spread through oral, vaginal or anal sex. HPV can also be transmitted during birth to infant and can lead to genital or respiratory infections.
Increasing collaboration activities of major players is expected to propel growth of the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market. For instance, in November 2018, GeoVax Labs Inc. announced collaboration with Virometix. The collaboration focuses on development of therapeutic vaccines for HPV infections. This collaboration will include preclinical animal testing of GeoVax’s MVA-Vectored HPV vaccines candidates in combination with Virometix synthetic HPV vaccines candidates.
Moreover, increasing regulatory approvals for novel therapies is expected to boost the human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market growth. For instance, in November 2017, Merck received the U.S. Food and Drug Administration approval for its Prevymis (letermovir) tablets and intravenous (IV) injection for prophylaxis of CMV infections and CMV seropositive recipients.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 37 market data tables and 33 figures on “human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market” - Global forecast to 2026”
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.